Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.48 USD | -0.85% | -1.02% | -24.75% |
02/04 | EyePoint Pharmaceuticals, Inc. Expands Scientific Advisory Board | CI |
18/03 | EyePoint Pharmaceuticals, Inc.(NasdaqGM:EYPT) added to S&P Pharmaceuticals Select Industry Index | CI |
Evolution of the average Target Price on EyePoint Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering EyePoint Pharmaceuticals, Inc.
Mizuho Securities | |
JPMorgan Chase | |
Capital One Securities | |
HC Wainwright | |
JonesTrading Institutional Services | |
Chardan Research | |
Guggenheim | |
Cowen | |
Cantor Fitzgerald | |
B. Riley |
EPS Revisions
- Stock Market
- Equities
- EYPT Stock
- Consensus EyePoint Pharmaceuticals, Inc.